SIN3A and pulmonary arterial hypertension: Our recent study also confirmed that SIN3a was significantly downregulated in the lung samples of human PAH patients and animal models of PAH, and the restoration of SIN3a in PASMCs inhibited cell growth in vitro and animal models of PAH [21] (Figure 2).